Alnylam Pharmaceuticals (ALNY) Downgraded to Neutral, PT Lowered to $173 at Goldman Sachs
Tweet Send to a Friend
(Updated - February 16, 2024 7:46 AM EST)
Goldman Sachs analyst Salveen Richter downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Salveen Richter downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
